Delivery Order SPE2DR25D3404-SPE2DR26F5T9A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,993.43 to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a $2,652.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Mesalamine DR 400 mg capsules (180-count package) with a ceiling value of $4,200.95. This is a firm fixed-price delivery order with an ultimate completion date of November 6, 2025, issued without a set-aside designation. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. The contract represents a child order...
- The Defense Logistics Agency awarded a $4,252.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). This non-set-aside, competitively awarded contract is scheduled for completion by September 18, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,830.02 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's larger indefinite delivery vehicle with the DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.57 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This contract type is a firm fixed-price delivery order with no set-aside designation, executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.73 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count) with a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the federal government's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,991.90 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) on November 14, 2025, with completion expected by November 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mesalamine is a gastrointestinal anti-inflammatory medication commonly...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 14, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count) valued at $9,632.65. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,882.72 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location. This...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5T9ADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,250.30 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed-price contract. The award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical prime vendor agreement extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and the Defense Health Agency. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen regularly fulfills federal medical procurement requirements through competitively awarded delivery orders spanning multiple therapeutic domains in support of military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/25/25 |